Growth Metrics

Vertex Pharmaceuticals (VRTX) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Dec 2024 value amounting to -$2.08.

  • Vertex Pharmaceuticals' EPS (Weighted Average and Diluted) rose 4.74% to $4.20 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.21, marking a year-over-year increase of 814.07%. This contributed to the annual value of -$2.08 for FY2024, which is 114.97% down from last year.
  • Per Vertex Pharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at -$2.08 for FY2024, which was down 114.97% from $13.89 recorded in FY2023.
  • In the past 5 years, Vertex Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $13.89 in FY2023 and a low of -$2.08 during FY2024.
  • Over the past 3 years, Vertex Pharmaceuticals' median EPS (Weighted Average and Diluted) value was $12.82 (recorded in 2022), while the average stood at $8.21.
  • In the last 5 years, Vertex Pharmaceuticals' EPS (Weighted Average and Diluted) skyrocketed by 128.16% in 2020 and then crashed by 114.97% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at $10.29 in 2020, then dropped by 12.44% to $9.01 in 2021, then skyrocketed by 42.29% to $12.82 in 2022, then climbed by 8.35% to $13.89 in 2023, then crashed by 114.97% to -$2.08 in 2024.